These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 11697576

  • 1. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M, Hatzimanolis J, Lykouras L.
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
    [Abstract] [Full Text] [Related]

  • 2. Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine.
    Markianos M, Hatzimanolis J, Lykouras L, Christodoulou GN.
    Schizophr Res; 2002 Jul 01; 56(1-2):11-7. PubMed ID: 12084414
    [Abstract] [Full Text] [Related]

  • 3. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S, Zipursky RB, Remington G.
    Am J Psychiatry; 1999 Feb 01; 156(2):286-93. PubMed ID: 9989565
    [Abstract] [Full Text] [Related]

  • 4. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R, Okumura M, Ito H, Takano A, Takahashi H, Takano H, Maeda J, Okubo Y, Suhara T.
    J Clin Psychiatry; 2010 Sep 01; 71(9):1131-7. PubMed ID: 20361897
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M, Hatzimanolis J, Lykouras L.
    Psychopharmacology (Berl); 2001 Aug 01; 157(1):55-9. PubMed ID: 11512043
    [Abstract] [Full Text] [Related]

  • 6. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S, Reckless GE, Barlow KB, Nobrega JN, Kapur S.
    Schizophr Res; 2008 Oct 01; 105(1-3):224-35. PubMed ID: 18710798
    [Abstract] [Full Text] [Related]

  • 7. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
    Reuss B, Unsicker K.
    Mol Cell Neurosci; 2001 Aug 01; 18(2):197-209. PubMed ID: 11520180
    [Abstract] [Full Text] [Related]

  • 8. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.
    Bernardo M, Parellada E, Lomeña F, Catafau AM, Font M, Gómez JC, López-Carrero C, Gutiérrez F, Pavía J, Salamero M.
    Psychiatry Res; 2001 Aug 25; 107(2):87-97. PubMed ID: 11530275
    [Abstract] [Full Text] [Related]

  • 9. The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro.
    McCormick PN, Kapur S, Graff-Guerrero A, Raymond R, Nobrega JN, Wilson AA.
    Neuropsychopharmacology; 2010 Jul 25; 35(8):1826-35. PubMed ID: 20410873
    [Abstract] [Full Text] [Related]

  • 10. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
    Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA, Houle S.
    Am J Psychiatry; 1998 Jul 25; 155(7):921-8. PubMed ID: 9659858
    [Abstract] [Full Text] [Related]

  • 11. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
    Kapur S, Remington G.
    Annu Rev Med; 2001 Jul 25; 52():503-17. PubMed ID: 11160792
    [Abstract] [Full Text] [Related]

  • 12. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
    Tauscher J, Küfferle B, Asenbaum S, Fischer P, Pezawas L, Barnas C, Tauscher-Wisniewski S, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1999 Jan 25; 141(2):175-81. PubMed ID: 9952042
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.
    Kapur S, Remington G.
    Biol Psychiatry; 2001 Dec 01; 50(11):873-83. PubMed ID: 11743942
    [Abstract] [Full Text] [Related]

  • 14. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.
    Kinon BJ, Stauffer VL, McGuire HC, Kaiser CJ, Dickson RA, Kennedy JS.
    J Am Med Dir Assoc; 2003 Dec 01; 4(4):189-94. PubMed ID: 12837139
    [Abstract] [Full Text] [Related]

  • 15. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
    Citrome L, Volavka J, Czobor P, Sheitman B, Lindenmayer JP, McEvoy J, Cooper TB, Chakos M, Lieberman JA.
    Psychiatr Serv; 2001 Nov 01; 52(11):1510-4. PubMed ID: 11684748
    [Abstract] [Full Text] [Related]

  • 16. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.
    Pilowsky LS, Busatto GF, Taylor M, Costa DC, Sharma T, Sigmundsson T, Ell PJ, Nohria V, Kerwin RW.
    Psychopharmacology (Berl); 1996 Mar 01; 124(1-2):148-53. PubMed ID: 8935810
    [Abstract] [Full Text] [Related]

  • 17. Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain.
    Bruggeman R, Westerink BH, Timmerman W.
    Eur J Pharmacol; 1997 Apr 11; 324(1):49-56. PubMed ID: 9137912
    [Abstract] [Full Text] [Related]

  • 18. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
    David SR, Taylor CC, Kinon BJ, Breier A.
    Clin Ther; 2000 Sep 11; 22(9):1085-96. PubMed ID: 11048906
    [Abstract] [Full Text] [Related]

  • 19. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
    Kalkman HO, Loetscher E.
    Eur J Pharmacol; 2003 Feb 21; 462(1-3):33-40. PubMed ID: 12591093
    [Abstract] [Full Text] [Related]

  • 20. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
    de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D.
    Am J Psychiatry; 2003 Feb 21; 160(2):303-9. PubMed ID: 12562577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.